导航
Language

Chinese

Japanese

SERVICE AREA

nh

API&INTERMEDIATE

nh

Fine Chemicals 

nh

Others

nh

ABOUT US

Jiangsu Wanzhen Pharmaceutical Technology Co., Ltd.

Jiangsu Wanzhen Pharmaceutical Technology Co., Ltd. was established in 2017 and is a wholly foreign-owned subsidiary of Huada (Hong Kong) Trading Co., Ltd. The company is located in the national pharmaceutical science and technology innovation park-Jiangsu Life Science and Technology Innovation Park, mainly engaged in the international trade and development of APIs, intermediates and chemical products. The market covers Europe, the United States, Japan and Southeast Asia. It is one of the well-known companies in the chemical and pharmaceutical trade.

 

Jiangsu Wanzhen Pharmaceutical Technology Co., Ltd. is a diversified company. Our company is committed to the development and research of medical technology, closely cooperating with key laboratories of surrounding universities, using years of market resources, striving to improve the independent innovation ability of enterprises...

PRODUCTS

Our company is committed to the development and research of medical technology, closely cooperating with key laboratories of surrounding universities, using years of market resources, striving to improve the independent innovation ability of enterprises, keeping up with the development trend of the international pharmaceutical market, and constantly providing source of power for the development of enterprises.

Amlodipine Besylate
Amlodipine Besylate
Fasudil Hydrochloride
Fasudil Hydrochloride
Glimepiride
Glimepiride
Bezafibrate
Bezafibrate
Temozolomide
Temozolomide
Gefitinib
Gefitinib
Tadalafil
Tadalafil
Safinamide
Safinamide
Buprenorphine Hydrochloride
Buprenorphine Hydrochloride
Rasagiline Mesylate
Rasagiline Mesylate

NEWS

CPhI World Pharmaceutical Raw Materials China Exhibition

2020

08 21

CPhI World Pharmaceutical Raw Materials China Exhibition
At the 19th World Pharmaceutical Raw Materials China Exhibition, the sales team held talks with customers from Eastern Europe, Asia, Africa, South America and other regions, shared industry trends, exchanged market information, chatted with old customers about cooperation plans, and obtained Inquiries from many new customers have opened up more windows for business expansion.
Clinical trials are an important stage in the development of drugs/medical devices and an important means to improve the development of medical science and technology

2020

08 21

Clinical trials are an important stage in the development of drugs/medical devices and an important means to improve the development of medical science and technology
Clinical trials are an important stage in the development of drugs/medical devices and an important means to improve the development of medical science and technology. How to achieve standardized management of clinical research, simplify research links, so that researchers can better implement standard operating procedures, improve research quality and level, ensure the accuracy, reliability, and scientific credibility of test results, thereby effectively shortening the development cycle of new drugs and speeding up drugs The application and registration process has become the key for new drug R&D organizations to gain a foothold in the market and defeat competitors.
my country will try to establish a long-term mechanism for the popularization of Chinese medicine culture

2020

08 21

my country will try to establish a long-term mechanism for the popularization of Chinese medicine culture
The State Administration of Traditional Chinese Medicine held a press conference in Beijing on the 13th, announcing that the first "Traditional Chinese Medicine in China · Culture and Science Promotion Week" will be launched in Beijing in the near future. The person in charge stated at the press conference that my country will try to establish a long-term mechanism for the popularization of Chinese medicine culture.
China

2020

08 21

China's accelerated price reform, major moves in the pharmaceutical sector are expected
Chinese Premier Li Keqiang recently presided over an executive meeting of the State Council to make arrangements to speed up price reform.As the most effective “baton” of the market, “price” is the core force that allows the market to play a decisive role. Reforms surrounding prices have also become a hard bone that must be gnawed under market-oriented reforms.
nh

Our company is committed to the development and research of medical technology, closely cooperating with key laboratories of surrounding universities, using many years of market resources, striving to improve the independent innovation ability of enterprises, keeping up with the development trend of the international pharmaceutical market, and constantly providing source of power for the development of enterprises.

Contact information

nh

D6-1104, Jiangsu Life Science and Technology Innovation Park, No. 9 Weidi Road, Qixia District, Nanjing

Copyright: Jiangsu Wanzhen Pharmaceutical Technology Co., Ltd.   苏ICP备12012017号-1

Technical support: www.300.cn Nanjing